Oral switch noninferior for low-risk S. Aureus bloodstream infection
Jan 26, 2024
Early oral antimicrobial therapy was noninferior to intravenous standard therapy for low-risk bloodstream infection.
Eye ointments sold at Walmart, CVS recalled due to infection risk
Feb 27, 2024
Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection.
More eye drops recalled due to infection danger
Nov 02, 2023
The new recall affects certain LEADER brand eye drops; the FDA says it found unsanitary conditions in a facility where they are manufactured.
FDA warns eye drops from major brands may cause infection
Oct 30, 2023
Twenty-six products can cause eye infection and blindness, an advisory warns.
ACP: Next-generation antibiotics underused for gram-negative infections
Apr 22, 2024
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
Federal final rule drops bring cries of ‘flawed,’ ‘aggressive,’ ‘dramatic’ from senior living...
By
Kimberly Bonvissuto
Apr 25, 2024
Late April brought a shower of regulatory changes as the federal government dropped four major final rules this week that the senior living and care industry is calling “flawed,” “aggressive” and...
Certain diets may protect against heart disease with type 1 diabetes
Jul 16, 2024
Higher adherence was tied to lower inflammatory marker levels over time.
Higher inflammation from early adulthood linked to worse cognition
Jul 08, 2024
Worse executive function and processing speeding were seen with consistently higher or moderate/increasing inflammation.
Commercial insurance market in ‘state of flux’ for senior housing and care
By
Kathleen Steele Gaivin
Jul 22, 2024
The commercial insurance market for long-term care operators “is in a state of flux, influenced by both lingering effects of the pandemic and broader economic factors,” Janice Loper, vice president...
FDA approves new antibiotic for three indications
Apr 08, 2024
Zevtera is approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections and bacterial pneumonia.